Journal of Applied Pharmacy
Open Access

Integrating Pharmacists into Multidisciplinary Teams for Infectious Disease Care

Doris Kayla^{* *}Correspondence: Doris Kayla, Department of Pharmacy, University of Oslo, Oslo, Norway, Email:

Author info »

Description

Infectious diseases pose significant challenges to global health, requiring coordinated, comprehensive care to manage effectively. The integration of pharmacists into multidisciplinary teams for infectious disease care has emerged as a critical strategy for enhancing patient outcomes, optimizing antimicrobial use, and improving overall healthcare efficiency. This article describes the role of pharmacists in these teams, the benefits of their integration, and the impact on infectious disease management [1,2].

The role of pharmacists in infectious disease care

Pharmacists bring unique expertise to infectious disease care, contributing in several critical areas

Antimicrobial stewardship: Pharmacists play a pivotal role in Antimicrobial Stewardship Programs (ASPs), promoting the appropriate use of antibiotics to combat resistance and improve patient outcomes. They review antimicrobial prescriptions, recommend optimal drug choices, dosages, and durations, and monitor patient responses to therapy.

Medication management: Pharmacists ensure that patients receive the most effective, safe, and cost-efficient medications. They assess potential drug interactions, adjust dosages for patients with renal or hepatic impairment, and provide therapeutic drug monitoring for medications requiring precise dosing, such as aminoglycosides and vancomycin [3-5].

Patient education and counseling: Pharmacists educate patients on the proper use of antimicrobial medications, potential side effects, and the importance of adherence to prescribed regimens. They provide information on infection prevention and the significance of completing full courses of antibiotics to prevent resistance.

Clinical consultation: Pharmacists participate in clinical rounds, offering their expertise in selecting and managing antimicrobial therapies [1]. They collaborate with physicians, nurses, and other healthcare professionals to develop and implement treatment plans tailored to individual patient needs.

Infection prevention and control: Pharmacists contribute to infection prevention and control efforts by advising on the use of prophylactic antimicrobials, monitoring infection trends, and educating healthcare staff on best practices for preventing Healthcare-Associated Infections (HAIs).

Benefits of integrating pharmacists into multidisciplinary teams

Integrating pharmacists into multidisciplinary teams for infectious disease care offers numerous benefits

Reduction in inappropriate prescribing: Pharmacists' involvement in ASPs leads to a significant reduction in inappropriate antimicrobial prescribing [6-8]. They provide evidence-based recommendations that help clinicians choose the right drug, dose, and duration, reducing the risk of resistance and adverse effects.

Improved patient outcomes: Pharmacists' expertise in antimicrobial pharmacotherapy ensures that patients receive the most effective treatment, leading to faster recovery times, reduced length of hospital stays, and lower mortality rates.

Minimized adverse drug reactions: Pharmacists' thorough medication reviews help identify and prevent potential drug interactions and adverse effects, ensuring that patients receive safe and appropriate therapies.

Personalized care: Pharmacists consider individual patient factors, such as age, weight, kidney function, and drug allergies, to tailor treatments that minimize risks and maximize benefits.

Cost savings: Pharmacists' recommendations for cost-effective therapies and their role in preventing infections contribute to significant cost savings for healthcare systems. By reducing unnecessary hospitalizations and treatments, pharmacists help optimize resource use.

Streamlined workflow: The integration of pharmacists into multidisciplinary teams allows other healthcare providers to focus on their core responsibilities, enhancing overall workflow and efficiency in healthcare settings.

Education for healthcare staff: Pharmacists provide ongoing education and training for healthcare staff on antimicrobial stewardship, infection control, and best practices for managing infectious diseases. This continuous education helps maintain high standards of care and ensures that staff stay updated on the latest guidelines and practices.

Patient education: Pharmacists' role in educating patients about their medications and infection prevention helps improve adherence to treatments and reduces the risk of treatment failure and recurrent infections.

Impact on infectious disease management

Integrating pharmacists into multidisciplinary teams has a profound impact on the management of infectious diseases:

Stewardship programs: Pharmacists' leadership in ASPs is crucial in reducing the emergence and spread of antibiotic resistance. They help implement policies that promote the judicious use of antibiotics and monitor resistance patterns to guide empirical therapy.

Research and development: Pharmacists contribute to research on new antimicrobial agents and resistance mechanisms, advancing the development of innovative treatments and strategies to combat resistant infections.

Expertise in infectious diseases: Pharmacists' specialized knowledge in infectious diseases enables them to manage complex infections, such as Multi Drug-Resistant Organisms (MDROs), HIV, hepatitis, and fungal infections. They provide guidance on the use of novel therapies and combination treatments that are often required for these challenging cases.

Support for immunocompromised patients: Pharmacists play a key role in the care of immunocompromised patients, such as those undergoing chemotherapy or organ transplantation [8-10]. They ensure that these patients receive appropriate prophylaxis and treatment for infections, minimizing their risk of complications.

Vaccination programs: Pharmacists are increasingly involved in vaccination programs, helping to prevent the spread of infectious diseases within communities. They provide immunizations, educate the public on the importance of vaccines, and support public health campaigns aimed at increasing vaccination rates.

Community outreach: Pharmacists engage in community outreach efforts to educate the public on infection prevention, hygiene, and the appropriate use of antibiotics. These efforts contribute to greater awareness and understanding of infectious diseases, leading to improved public health outcomes.

Conclusion

Integrating pharmacists into multidisciplinary teams for infectious disease care is a vital strategy for improving patient outcomes, enhancing the appropriate use of antimicrobials, and addressing the challenges of antibiotic resistance. Pharmacists' expertise in medication management, patient education, and clinical consultation adds significant value to the care of patients with infectious diseases. As the healthcare landscape continues to evolve, the role of pharmacists in multidisciplinary teams will remain essential in ensuring comprehensive, effective, and efficient infectious disease care.

References

1. Bhattacharyya T, Levin R, Vrahas MS, Solomon DH. Nonsteroidal antiinflammatory drugs and nonunion of humeral shaft fractures. Arthritis Rheum. 2005;53(3):364-367.

   [Crossref] [Google Scholar] [PubMed]

2. Hyllested M, Jones S, Pedersen JL, Kehlet H. Comparative effect of paracetamol, NSAIDs or their combination in postoperative pain management: a qualitative review. Br J Anaesth. 2002;88(2):199-214.

   [Crossref] [Google Scholar] [PubMed]

3. Verkleij SP, Luijsterburg PA, Bohnen AM, Koes BW, Bierma-Zeinstra SM. NSAIDs vs. acetaminophen in knee and hip osteoarthritis: A systematic review regarding heterogeneity influencing the outcomes. Osteoarthritis Cartilage. 2011;19(8):921-929.

   [Crossref] [Google Scholar] [PubMed]

4. Chan AT, Manson JE, Albert CM, Chae CU, Rexrode KM, Curhan GC, et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation. 2006;113(12):1578-1587.

   [Crossref] [Google Scholar] [PubMed]

5. Curhan GC, Knight EL, Rosner B, Hankinson SE, Stampfer MJ. Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med. 2004;164(14):1519-1524.

   [Crossref] [Google Scholar] [PubMed]

6. Pezzia C, Sanders C, Welch S, Bowling A, Lee WM. Psychosocial and behavioral factors in acetaminophen-related acute liver failure and liver injury. J Psychosom Res. 2017;101:51-57.

   [Crossref] [Google Scholar] [PubMed]

7. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240-249.

   [CrossRef] [Google Scholar] [PubMed]

8. Quick JD, Hogerzeil HV, Rankin JR, Dukes MN, Laing R, Garnett A, et al. Managing drug supply: the selection, procurement, distribution, and use of pharmaceuticals. West Hartford, Connecticut: Kumarian Press; 1997.

   [Google Scholar]

9. Waako PJ, Odoi-Adome R, Obua C, Owino E, Tumwikirize W, Ogwal-Okeng J, et al. Existing capacity to manage pharmaceuticals and related commodities in East Africa: An assessment with specific reference to antiretroviral therapy. Hum Resour Health. 2009;7(1):1-5.

   [CrossRef] [Google Scholar]

10. Kangwana BB, Njogu J, Wasunna B, Kedenge SV, Memusi DN, Goodman CA, et al. Malaria drug shortages in Kenya: a major failure to provide access to effective treatment. Am J Trop Med Hyg. 2009;80(5):737.

    [CrossRef] [Google Scholar]